As of 2026-09-14, the Relative Valuation of Aldeyra Therapeutics Inc (ALDX) is (7.76) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.34 USD, the upside of Aldeyra Therapeutics Inc based on Relative Valuation is -679.0%.
The range of the Relative Valuation is (7.22) - (8.90) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 23.3x | 21.1x |
| Forward P/E multiples | 15.6x - 23.4x | 19.5x |
| Fair Price | (7.22) - (8.90) | (7.76) |
| Upside | -639.0% - -764.5% | -679.0% |
| Date | P/E |
| 2026-09-11 | -3.51 |
| 2026-09-10 | -3.82 |
| 2026-09-09 | -3.92 |
| 2026-09-08 | -4.03 |
| 2026-09-04 | -3.87 |
| 2026-09-03 | -3.87 |
| 2026-09-02 | -3.90 |
| 2026-09-01 | -3.90 |
| 2026-08-31 | -3.87 |
| 2026-08-28 | -3.89 |
| 2026-08-27 | -4.03 |
| 2026-08-26 | -4.08 |
| 2026-08-25 | -4.06 |
| 2026-08-24 | -3.98 |
| 2026-08-21 | -3.98 |
| 2026-08-20 | -3.92 |
| 2026-08-19 | -4.13 |
| 2026-08-18 | -4.06 |
| 2026-08-17 | -4.08 |
| 2026-08-14 | -4.08 |
| 2026-08-13 | -3.77 |
| 2026-08-12 | -3.98 |
| 2026-08-11 | -3.95 |
| 2026-08-10 | -3.95 |
| 2026-08-07 | -4.06 |
| 2026-08-06 | -4.16 |
| 2026-08-05 | -4.19 |
| 2026-08-04 | -4.06 |
| 2026-08-03 | -4.00 |
| 2026-07-31 | -4.03 |
| 2026-07-30 | -4.19 |
| 2026-07-29 | -4.21 |
| 2026-07-28 | -4.13 |
| 2026-07-27 | -4.15 |
| 2026-07-24 | -3.98 |
| 2026-07-23 | -4.06 |
| 2026-07-22 | -4.45 |
| 2026-07-21 | -4.58 |
| 2026-07-20 | -4.45 |
| 2026-07-17 | -4.42 |
| 2026-07-16 | -4.50 |
| 2026-07-15 | -5.02 |
| 2026-07-14 | -5.05 |
| 2026-07-13 | -5.05 |
| 2026-07-10 | -5.42 |
| 2026-07-09 | -6.02 |
| 2026-07-08 | -5.57 |
| 2026-07-07 | -5.84 |
| 2026-07-06 | -5.97 |
| 2026-07-02 | -5.94 |